Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Supernus Pharm (SUPN)

$21.82 0.81 (3.58%)

16:07 EST SUPN Stock Quote Delayed 15 Minutes

Volume:

Previous Close $21.82

Market Cap 1.13B

PE Ratio 15.81

EPS 1.38

Volume (Avg. Vol.) 691,000

Day's Range 21.76 - 22.62

52-Week Range 19.35 - 43.05

Dividend & Yield N/A (N/A)

SUPN Stock Predictions, Articles, and Supernus Pharm News

From the Web

Supernus Pharma up 10% premarket on updated late-stage SPN-810 results

From Seeking Alpha Dec 10, 2019

Supernus Pharmaceuticals (NASDAQ:SUPN) is up 10% premarket on light volume in reaction to updated data from a Phase 3 clinical trial, P301, evaluating SPN-810 for the treatment of impulsive aggression

The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares

From Benzinga Dec 10, 2019

The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 9.) Acceleron Pharma Inc (NASDAQ:...

Putting My Covered Call Strategy to Work With 2 Dinged Biotech Stocks

From Real Money Dec 6, 2019

Sharp drops in Heron Therapeutics and Supernus Pharmaceuticals have presented opportunities to make lemonade out of lemons.

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN): What Does Its Beta Value Mean For Your Portfolio?

From Simply Wall St Dec 4, 2019

If you own shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-supn/supernus-pharmaceuticals/news/supernus-pharmaceuticals-inc-nasdaqsupn-what-does-its-beta-value-mean-for-your-portfolio/">Read More...</a></div>

Do You Know What Supernus Pharmaceuticals, Inc.’s (NASDAQ:SUPN) P/E Ratio Means?

From Simply Wall St Nov 21, 2019

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We’ll apply a basic P/E ratio analysis to Supernus Pharmaceuticals, Inc.’s<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-supn/supernus-pharmaceuticals/news/do-you-know-what-supernus-pharmaceuticals-inc-s-nasdaqsupn-p-e-ratio-means/">Read More...</a></div>

The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat

From Benzinga Nov 12, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 11) ACADIA Pharmaceuticals...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

F

Strong Sell